Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
종목 코드 INSP
회사 이름Inspire Medical Systems Inc
상장일May 03, 2018
CEOMr. Timothy P. (Tim) Herbert
직원 수1246
유형Ordinary Share
회계 연도 종료May 03
주소5500 Wayzata Blvd Ste 1600
도시GOLDEN VALLEY
증권 거래소NYSE Consolidated
국가United States of America
우편 번호55416-1237
전화17639575037
웹사이트https://www.inspiresleep.com/
종목 코드 INSP
상장일May 03, 2018
CEOMr. Timothy P. (Tim) Herbert
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음